Related Experiment Video
Updated: Sep 28, 2025

05:34
Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
Published on: June 6, 2025
840
Systemic evolutionary chemical space exploration for drug discovery.
Chong Lu1, Shien Liu1, Weihua Shi1
1Keen Therapeutics Co., Ltd., Shanghai, China.
Journal of Cheminformatics
|April 2, 2022
Summary
A new computational platform, systemic evolutionary chemical space explorer (SECSE), aids drug discovery by exploring novel chemical entities. It uses fragment-based design principles with AI to find promising small molecules for targets like PHGDH.
Area of Science:
- Computational chemistry
- Drug discovery
- cheminformatics
Background:
- Chemical space exploration is crucial for identifying novel chemical entities.
- Computational de novo design offers an advantage over limited chemical libraries.
- Fragment-based drug design principles inspire new approaches.
Purpose of the Study:
- To introduce the systemic evolutionary chemical space explorer (SECSE) platform for de novo drug design.
- To demonstrate SECSE's capability in generating novel and diverse small molecules.
- To present SECSE as an open-source tool for virtual hit generation.
Main Methods:
- SECSE employs a miniaturized "lego-building" approach within target protein pockets.
- Human intelligence and deep learning are integrated for enhanced search and optimization.
- The platform frames virtual hit generation as a computational search problem.
Main Results:
- SECSE successfully identified novel and diverse small molecules against phosphoglycerate dehydrogenase (PHGDH).
- The generated molecules serve as attractive starting points for further drug validation.
- The platform's efficacy in exploring chemical space for hit finding was demonstrated.
Conclusions:
- SECSE is a potent computational tool for de novo design and chemical space exploration.
- The integration of AI and fragment-based principles enhances virtual screening capabilities.
- SECSE provides an open-source solution for accelerating the discovery of novel chemical entities.
Keywords:
Chemical space explorationDe novo drug designDeep learningFragment-based drug discoveryPHGDHMore Related Videos
Related Concept Videos
Drug Discovery: Overview
9.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.1K
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Effects of Chemicals: Overview
1.5K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.5K

